Cyclacel Pharmaceuticals Inc/ US23254L8019 /
2024-03-28 3:37:32 PM | Chg. +0.0650 | Volume | Bid2024-03-28 | Ask2024-03-28 | High | Low |
---|---|---|---|---|---|---|
2.0250USD | +3.32% | 13,880 Turnover: 26,114.4338 |
1.9800Bid Size: 100 | 2.0700Ask Size: 400 | 2.0700 | 1.9900 |
GlobeNewswire
03-19
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Bu...
GlobeNewswire
03-13
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
03-07
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented...
GlobeNewswire
01-30
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
GlobeNewswire
01-08
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
GlobeNewswire
2023-12-22
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Ma...
GlobeNewswire
2023-12-18
Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CD...
GlobeNewswire
2023-11-30
Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC
GlobeNewswire
2023-11-28
Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Repor...
GlobeNewswire
2023-11-13
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
GlobeNewswire
2022-03-28
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire
2022-03-22
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire
2022-03-09
Cyclacel Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conference
GlobeNewswire
2022-02-07
Cyclacel Pharmaceuticals to Participate in 2022 BIO CEO & Investor Conference
GlobeNewswire
2021-12-23
Cyclacel Pharmaceuticals to Participate in Biotech Showcase 2022 Virtual Conference
GlobeNewswire
2021-11-10
Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-11-05
Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With L...
GlobeNewswire
2021-10-29
Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update
GlobeNewswire
2021-08-11
Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update